Products Quality Lab Reports Knowledge Calculator FAQ 💬 Get in touch
Glow70 vial
Skin

Glow70.

Available Variants
70 mg

Research area: Skin

🛡️
For research purposes only. Not intended for use in humans or animals.
Skin & anti-aging research

About Glow70

Glow70 is studied in dermatological and anti-aging research, e.g. in relation to skin and pigmentation models. Three distinct tissue-regeneration research mechanisms are combined: vascular signal amplification, cell migration, and collagen-related gene expression via the copper component.

Research Application

Discussed as a combination approach in skin-regeneration research that bundles three distinct mechanisms — vascular signal amplification, cell migration, and collagen-related gene expression. No dedicated study exists for the combination itself.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

70 mg
Lyophilized powder
Skin
see lab reports →
Combination: TB-500 (43 aa) + BPC-157 (15 aa) + GHK-Cu (tripeptide-copper complex)
The combination has not been clinically studied as a whole; the evidence relates to the three individual components.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

The evidence base for skin and pigmentation peptides is largely based on preclinical and early clinical investigations.

  • Hsieh MJ, et al. J Mol Med. 2017;95(3):323–333. PMID 27847966
  • Malinda KM, et al. J Invest Dermatol. 1999;113(3):364–368. PMID 10469335
  • Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PMID 29986520

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about Glow70?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram
← Back to overview